Published in Joint Bone Spine on September 01, 2004
Calcium deposition in osteoarthritic meniscus and meniscal cell culture. Arthritis Res Ther (2010) 1.27
Pathophysiology of articular chondrocalcinosis--role of ANKH. Nat Rev Rheumatol (2010) 1.14
The progressive ankylosis protein regulates cementum apposition and extracellular matrix composition. Cells Tissues Organs (2011) 1.11
Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today (2008) 0.90
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81
Fibroblast-like synoviocytes induce calcium mineral formation and deposition. Arthritis (2014) 0.76
Calcium pyrophosphate deposition disease in the ankle joint: a case report. J Can Chiropr Assoc (2017) 0.75
Gout. Lancet (2009) 4.33
Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum (2003) 3.66
New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum (2005) 2.48
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis (2012) 1.95
Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum (2004) 1.89
Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med (2009) 1.86
Gout: why is this curable disease so seldom cured? Ann Rheum Dis (2012) 1.84
Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol (2004) 1.83
Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity. Arthritis Rheum (2002) 1.81
Contribution of clinical tests to the diagnosis of rotator cuff disease: a systematic literature review. Joint Bone Spine (2008) 1.65
Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet (2002) 1.63
Usefulness of ultrasonography for gout. Joint Bone Spine (2012) 1.57
From diagnosis to remission: place of MRI in eosinophilic fasciitis. Clin Rheumatol (2010) 1.53
Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. Arthritis Care Res (Hoboken) (2011) 1.50
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv (2012) 1.46
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine (2011) 1.41
Efficacy of joint lavage in knee osteoarthritis: meta-analysis of randomized controlled studies. Rheumatology (Oxford) (2009) 1.40
Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results. J Rheumatol (2013) 1.39
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A (2007) 1.29
Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis (2010) 1.27
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) (2009) 1.24
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res Ther (2006) 1.22
Sodium thiosulphate treatment of uraemic tumoral calcinosis. Rheumatology (Oxford) (2013) 1.21
Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol (2006) 1.21
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol (2007) 1.18
Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. Arthritis Rheum (2011) 1.15
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes (2012) 1.13
Estrogens, cartilage, and osteoarthritis. Joint Bone Spine (2003) 1.13
Effect of proteoglycan depletion on T2 mapping in rat patellar cartilage. Radiology (2004) 1.12
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther (2007) 1.12
Developing a provisional definition of flare in patients with established gout. Arthritis Rheum (2012) 1.10
Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum (2007) 1.10
Dose-response relationship for exercise on severity of experimental osteoarthritis in rats: a pilot study. Osteoarthritis Cartilage (2004) 1.09
Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol (2013) 1.07
Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther (2005) 1.06
Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br J Clin Pharmacol (2002) 1.06
Achondroplasia: from genotype to phenotype. Joint Bone Spine (2007) 1.06
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res Ther (2008) 1.05
Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens (2015) 1.05
Ultrasonography in gout: a case-control study. Clin Exp Rheumatol (2012) 1.03
IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis (2006) 1.03
Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02
Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006. Biomed Mater Eng (2009) 1.00
Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? J Rheumatol (2007) 1.00
Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: influence on Disease Activity Score-28 values (SEA-Repro study part I). J Rheumatol (2010) 1.00
Genetics of Dupuytren's disease. Joint Bone Spine (2011) 0.98
Cyclic tensile stretch modulates proteoglycan production by intervertebral disc annulus fibrosus cells through production of nitrite oxide. J Cell Biochem (2003) 0.97
Factors influencing concordance between clinical and ultrasound findings in rheumatoid arthritis. J Rheumatol (2013) 0.97
TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine (2011) 0.96
Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J Biol Chem (2004) 0.96
Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res (2007) 0.95
Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol (2008) 0.95
International position paper on febuxostat. Clin Rheumatol (2010) 0.95
Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol (2003) 0.94
Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol (2014) 0.94
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis (2012) 0.93
A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis. J Rheumatol (2008) 0.92
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy. Arthritis Res Ther (2011) 0.92
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res (2011) 0.92
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis (2010) 0.92
Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J Rheumatol (2009) 0.91
Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families. J Rheumatol (2008) 0.91
Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. Arthritis Res Ther (2009) 0.90
Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al. Arthritis Rheum (2008) 0.90
Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. Arthritis Rheum (2006) 0.90
Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes. Arthritis Res Ther (2007) 0.89
The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte. J Biol Chem (2010) 0.89
PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am J Physiol Cell Physiol (2002) 0.89
Therapeutic perspectives on uricases for gout. Joint Bone Spine (2012) 0.88
Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum (2012) 0.88
Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis? Joint Bone Spine (2007) 0.88
Role for imaging studies in ankylosing spondylitis. Joint Bone Spine (2010) 0.88
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. Arthritis Res Ther (2013) 0.88
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. FEBS Lett (2004) 0.88
Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol (2010) 0.88
An exploratory ultrasound study of early gout. Clin Exp Rheumatol (2011) 0.88
Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. Joint Bone Spine (2010) 0.87
Prognostic value of early computed tomography in radiculopathy due to lumbar intervertebral disk herniation. A prospective study. Joint Bone Spine (2003) 0.87
Reproducibility of joint swelling assessment by sonography in patients with long-lasting rheumatoid arthritis (SEA-Repro study part II). J Rheumatol (2010) 0.87
Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Ann Rheum Dis (2012) 0.87
How to define responders in osteoarthritis. Curr Med Res Opin (2013) 0.86
Responsiveness in rheumatoid arthritis. a report from the OMERACT 11 ultrasound workshop. J Rheumatol (2013) 0.85
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Arthritis Rheum (2005) 0.85
Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Joint Bone Spine (2012) 0.85
Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol. Nat Clin Pract Rheumatol (2006) 0.85
Assessment of dynamic humeral centering in shoulder pain with impingement syndrome: a randomised clinical trial. Ann Rheum Dis (2011) 0.85
Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol (2009) 0.84
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging (2015) 0.84
In vivo high-resolution MRI (7T) of femoro-tibial cartilage changes in the rat anterior cruciate ligament transection model of osteoarthritis: a cross-sectional study. Rheumatology (Oxford) (2010) 0.83